Jane Street
ALBO

Jane Street’s Albireo Pharma Inc ALBO Stock Holding History

Jane Street’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-18,900
Closed -$590K – 11070
2021
Q3 		$590K Buy
+18,900
New +$585K ﹤0.01% 6973
2020
Q4 		– Sell
-20,800
Closed -$694K – 8333
2020
Q3 		$694K Buy
+20,800
New +$606K ﹤0.01% 4662

Other funds holding ALBO

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

Jane Street's ALBO Position: Q4 2022 in Review

Jane Street sold out of Albireo Pharma Inc (ALBO) in Q4 2022, closing a stake of 61,652 shares — an estimated $1.19M sold.

Jane Street first reported a position in ALBO in Q4 2013 and held it in 3 quarters. The position peaked at $1.19M in Q3 2022. 96 funds tracked by Wall St. Rank hold ALBO as of Q4 2022.

  • Jane Street reported no remaining Albireo Pharma Inc position as of Q4 2022 after selling out during the quarter.
  • Jane Street sold 61,652 Albireo Pharma Inc shares in Q4 2022, an estimated $1.19M.
  • Jane Street first reported a position in Albireo Pharma Inc in Q4 2013 and held it in 3 quarters.
  • Jane Street's Albireo Pharma Inc position peaked at $1.19M in Q3 2022.
  • 96 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q4 2022.

Based on Jane Street's 13F filing for Q4 2022, filed 15 Feb 2023.